{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:17:30Z","timestamp":1793146650568,"version":"4.5.0"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Thrombotic thrombocytopenic purpura (TTP) is a rare but life-threatening hemolytic disorder with severe implications during pregnancy, characterized by microangiopathic hemolytic anemia (MAHA), severe thrombocytopenia, and systemic microvascular thrombosis. The condition arises from a severe deficiency in the ADAMTS13 enzyme, whether congenital or acquired, leading to the accumulation of ultra-large von Willebrand factor (vWF) multimers and widespread platelet aggregation. Pregnancy itself exacerbates TTP due to physiological reductions in ADAMTS13 activity, necessitating a high degree of clinical vigilance. This review addresses the etiology, diagnostic challenges, clinical presentation, and management of TTP in pregnancy, focusing on clinical relevance and emphasizing the importance of prompt therapeutic plasma exchange (TPE) and interdisciplinary care to optimize maternal and fetal outcomes.<\/jats:p>","DOI":"10.1515\/jpm-2024-0527","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T18:59:27Z","timestamp":1744829967000},"page":"727-732","source":"Crossref","is-referenced-by-count":6,"title":["Thrombotic thrombocytopenic purpura in pregnancy: a comprehensive review"],"prefix":"10.1515","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-277X","authenticated-orcid":false,"given":"Eman","family":"Alsulmi","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, College of Medicine , 48023 Imam Abdulrahman Bin Faisal University , Al Khobar , Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"2025070217081526072_j_jpm-2024-0527_ref_001","doi-asserted-by":"crossref","unstructured":"George, JN. Thrombotic thrombocytopenic purpura. N\u00a0Engl J Med 2006;354:1927\u201335. https:\/\/doi.org\/10.1056\/nejmcp053024.","DOI":"10.1056\/NEJMcp053024"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_002","doi-asserted-by":"crossref","unstructured":"Scully, M, Hunt, BJ, Benjamin, S, Liesner, R, Rose, P, Peyvandi, F, et al.. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012;158:323\u201335. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09167.x.","DOI":"10.1111\/j.1365-2141.2012.09167.x"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_003","doi-asserted-by":"crossref","unstructured":"Fakhouri, F, Scully, M, Prov\u00f4t, F, Blasco, M, Coppo, P, Noris, M, et al.. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. Blood 2020;136:2103\u201317. https:\/\/doi.org\/10.1182\/blood.2020005221.","DOI":"10.1182\/blood.2020005221"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_004","doi-asserted-by":"crossref","unstructured":"Terrell, DR, Williams, LA, Vesely, SK, L\u00e4mmle, B, Hovinga, JAK, George, JN. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J\u00a0Thromb Haemost 2005;3:1432\u20136. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01436.x.","DOI":"10.1111\/j.1538-7836.2005.01436.x"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_005","doi-asserted-by":"crossref","unstructured":"Moatti-Cohen, M, Garrec, C, Wolf, M, Boisseau, P, Galicier, L, Azoulay, E, et al.. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura. Blood 2012;119:5888\u201397. https:\/\/doi.org\/10.1182\/blood-2012-02-408914.","DOI":"10.1182\/blood-2012-02-408914"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_006","doi-asserted-by":"crossref","unstructured":"Iqbal, S, Zaidi, SZA, Motabi, IH, Alshehry, NF, AlGhamdi, MS, Tailor, IK. Thrombotic thrombocytopenic purpura\u2013analysis of clinical features, laboratory characteristics, and therapeutic outcome of 24 patients treated at a tertiary care center in Saudi Arabia. Pak J Med Sci 2016;32:1494\u20139. https:\/\/doi.org\/10.12669\/pjms.326.11274.","DOI":"10.12669\/pjms.326.11274"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_007","doi-asserted-by":"crossref","unstructured":"Sadler, JE. What\u2019s new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Progr 2016;2016:631\u20136. https:\/\/doi.org\/10.1182\/asheducation-2015.1.631.","DOI":"10.1182\/asheducation-2015.1.631"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_008","doi-asserted-by":"crossref","unstructured":"Sadler, JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008;112:11\u20138. https:\/\/doi.org\/10.1182\/blood-2008-02-078170.","DOI":"10.1182\/blood-2008-02-078170"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_009","doi-asserted-by":"crossref","unstructured":"Joly, BS, Coppo, P, Veyradier, A. Thrombotic thrombocytopenic purpura. Blood 2017;129:2836\u201346. https:\/\/doi.org\/10.1182\/blood-2016-10-709857.","DOI":"10.1182\/blood-2016-10-709857"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_010","doi-asserted-by":"crossref","unstructured":"Ferrari, B, Maino, A, Lotta, LA, Artoni, A, Pontiggia, S, Trisolini, SM, et al.. Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study. Orphanet J Rare Dis 2014;9:193. https:\/\/doi.org\/10.1186\/s13023-014-0193-6.","DOI":"10.1186\/s13023-014-0193-6"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_011","doi-asserted-by":"crossref","unstructured":"Pishko, AM, Marshall, AL. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Progr 2022;2022:303\u201311. https:\/\/doi.org\/10.1182\/hematology.2022000375.","DOI":"10.1182\/hematology.2022000375"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_012","doi-asserted-by":"crossref","unstructured":"Brown, MA, Magee, LA, Kenny, LC, Karumanchi, SA, McCarthy, F, Saito, S, et al.. International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 2018;72:24\u201343. https:\/\/doi.org\/10.1161\/hypertensionaha.117.10803.","DOI":"10.1161\/HYPERTENSIONAHA.117.10803"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_013","doi-asserted-by":"crossref","unstructured":"Frimat, M, Gnemmi, V, Stichelbout, M, Prov\u00f4t, F, Fakhouri, F. Pregnancy as a susceptible state for thrombotic microangiopathies. Front Med 2024;11:1343060. https:\/\/doi.org\/10.3389\/fmed.2024.1343060.","DOI":"10.3389\/fmed.2024.1343060"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_014","doi-asserted-by":"crossref","unstructured":"Fakhouri, F, Zuber, J, Fr\u00e9meaux-Bacchi, V, Loirat, C. Haemolytic uraemic syndrome. Lancet 2017;390:681\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(17)30062-4.","DOI":"10.1016\/S0140-6736(17)30062-4"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_015","doi-asserted-by":"crossref","unstructured":"Provan, D, Arnold, DM, Bussel, JB, Chong, BH, Cooper, N, Gernsheimer, T, et al.. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3:3780\u2013817. https:\/\/doi.org\/10.1182\/bloodadvances.2019000812.","DOI":"10.1182\/bloodadvances.2019000812"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_016","doi-asserted-by":"crossref","unstructured":"Zheng, XL, Vesely, SK, Cataland, SR, Coppo, P, Geldziler, B, Iorio, A, et al.. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J\u00a0Thromb Haemost 2020;18:2486\u201395. https:\/\/doi.org\/10.1111\/jth.15006.","DOI":"10.1111\/jth.15006"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_017","doi-asserted-by":"crossref","unstructured":"B\u00e9ranger, N, Coppo, P, Tsatsaris, V, Boisseau, P, Prov\u00f4t, F, Delmas, Y, et al.. Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience. Blood Adv 2024;8:183\u201392. https:\/\/doi.org\/10.1182\/bloodadvances.2023011972.","DOI":"10.1182\/bloodadvances.2023011972"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_018","doi-asserted-by":"crossref","unstructured":"Scully, M, Rayment, R, Clark, A, Westwood, JP, Cranfield, T, Gooding, R, et al.. A British Society for Haematology guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies. Br J Haematol 2023;00:1\u201318. https:\/\/doi.org\/10.1111\/bjh.19026.","DOI":"10.1111\/bjh.19026"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_019","doi-asserted-by":"crossref","unstructured":"Scully, M, Thomas, M, Underwood, M, Watson, H, Langley, K, Camilleri, RS, et al.. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood 2014;124:211\u20139. https:\/\/doi.org\/10.1182\/blood-2014-02-553131.","DOI":"10.1182\/blood-2014-02-553131"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_020","doi-asserted-by":"crossref","unstructured":"Wind, M, Gaasbeek, AGA, Oosten, LEM, Rabelink, TJ, van Lith, JMM, Sueters, M, et al.. Therapeutic plasma exchange in pregnancy: a\u00a0literature review. Eur J Obstet Gynecol Reprod Biol 2021;260:29\u201336. https:\/\/doi.org\/10.1016\/j.ejogrb.2021.02.027.","DOI":"10.1016\/j.ejogrb.2021.02.027"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_021","doi-asserted-by":"crossref","unstructured":"Chakravarty, EF, Murray, ER, Kelman, A, Farmer, P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011;117:1499\u2013506. https:\/\/doi.org\/10.1182\/blood-2010-07-295444.","DOI":"10.1182\/blood-2010-07-295444"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_022","doi-asserted-by":"crossref","unstructured":"Pham-Huy, A, Top, KA, Constantinescu, C, El-Cha\u00e2r, D. The use and impact of monoclonal antibody biologics during pregnancy: a literature review. CMAJ 2021;193:29.","DOI":"10.1503\/cmaj.202391"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_023","doi-asserted-by":"crossref","unstructured":"Odetola, O, Martin, KA, Dreyer, M, Rajan, P, Zakarija, A, Stein, BL. A safe and effective use of caplacizumab in pregnancy-related acquired thrombotic thrombocytopenic purpura. Br J Haematol 2023;202:879\u201382. https:\/\/doi.org\/10.1111\/bjh.18888.","DOI":"10.1111\/bjh.18888"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_024","doi-asserted-by":"crossref","unstructured":"Schimmer, RR, Sutter, T, Bachofner, A, Ranieri, E, Rodewald, AK, Kremer Hovinga, JA, et al.. Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab. Br J Haematol 2024;204:1994\u20138. https:\/\/doi.org\/10.1111\/bjh.19284.","DOI":"10.1111\/bjh.19284"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_025","doi-asserted-by":"crossref","unstructured":"Goel, R, Ness, PM, Takemoto, CM, Krishnamurti, L, King, KE, Tobian, AAR. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood 2015;125:1470\u20136. https:\/\/doi.org\/10.1182\/blood-2014-10-605493.","DOI":"10.1182\/blood-2014-10-605493"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_026","doi-asserted-by":"crossref","unstructured":"Brown, J, Potugari, B, Mazepa, MA, Kohli, R, Moliterno, AR, Brodsky, RA, et al.. Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura. Ann Hematol 2022;101:2159\u201367. https:\/\/doi.org\/10.1007\/s00277-022-04936-2.","DOI":"10.1007\/s00277-022-04936-2"},{"key":"2025070217081526072_j_jpm-2024-0527_ref_027","doi-asserted-by":"crossref","unstructured":"Jiang, Y, McIntosh, JJ, Reese, JA, Deford, CC, Kremer Hovinga, JA, L\u00e4mmle, B, et al.. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood 2014;123:1674\u201380. https:\/\/doi.org\/10.1182\/blood-2013-11-538900.","DOI":"10.1182\/blood-2013-11-538900"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0527\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0527\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:09:00Z","timestamp":1751476140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0527\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,4,28]]},"published-print":{"date-parts":[[2025,7,28]]}},"alternative-id":["10.1515\/jpm-2024-0527"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2024-0527","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}